Interaction between nitric oxide and cyclooxygenase pathways

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 54, Issue 4, 1996, Pages 229-238

  Di Rosa, Massimo ^a   Ialenti, Armando ^a   Ianaro, Angela ^a   Sautebin, Lidia ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLYCERYL TRINITRATE; ILOPROST; ISOSORBIDE DINITRATE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; VASODILATOR AGENT;

ENZYME REGULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029892889     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90053-8     Document Type: Review

References (127)

1. Furchgott R. E., Zawadski J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
2. Palmer R. M. J., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
3. Ignarro L. J., Buga G. M., Wood K. S., Byrns R. E., Chaudhuri G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9269.
4. Palmer R. M. J., Rees D. D., Ashton D. S., Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153: 1251-1256.
5. Sakuma I., Stuehr D. J., Gross S. S., Nathan C., Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 8664-8667
6. Rees D. D., Palmer R. M. J., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375-3378.
7. Garthwaite J., Charles S. L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intracellular messenger in the brain. Nature 1988; 336: 385-388.
8. G-monomethyl L-arginine on the response of the rat anococcygeus to NANC nerve stimulation. Br J Pharmacol 1989; 98: 1080-1082.
9. Nathan C., Hibbs J. B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70.
10. Schmidt H. H. H. W., Ulrich W. NO at work. Cell 1994; 78: 919-925.
11. Gaston B., Drazen J. M., Loscalzo J., Stamler J. S. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149: 538-551.
12. Knowles R. G., Moncada S. Nitric oxide syntheses in mammals. Biochem J 1994; 298: 249-258.
13. Sthuer D. J., Marletta M. A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ. J Immunol 1987; 139: 518-525.
14. McCall T. B., Palmer R. M. J., Moncada S. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur J Immunol 1991; 21: 2523-2527.
15. Radomski M., Palmer R. M. J., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-10047.
16. Busse R., Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990; 275: 87-90.
17. ω-amino-L-arginine. J Natl Cancer Inst 1992; 84: 1008-1016.
18. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
19. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
20. Rees D. D., Palmer R. M. J., Schulz R., Hodson H. F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746-752.
21. McCall T. B., Feelisch M., Palmer R. M. J., Moncada S. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. BrJ Pharmacol 1991; 102: 234-238.
22. Corbett J. A., Tilton R. G., Chang K. et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992; 41: 552-556.
23. Di Rosa M., Radomski M., Carnuccio R., Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 1990; 172: 1246-1252.
24. Palmer R. M. J., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
25. 4 on cavian pulmonary artery and aorta: characterization and mechanism. In: Levi R., Krell R. D., eds. Biology of the Leukotrienes. New York: New York Academy Science, 1988: 91.
26. G-Monomethyl-L-arginine differentially inhibits endothelium-dependent relaxation to bradykinin and 5-hydroxytryptamine in porcine coronary arteries. In: Moncada S., Higgs E. A., eds. Nitric Oxide from L-Arginine: a Bioregulatory System. Amsterdam: Elsevier, 1990:439.
27. Rimele T. J., Sturm R. J., Adams L. M. et al. Interactions of neutrophils with vascular smooth muscle: identification of neutrophil-derived relaxing factor. J Pharmacol Exp Ther 1988; 245: 102-111.
28. Sturm R. J., Holloway D. A., Buckley S. et al. Potential regulatory role of inflammatory cells on local vascular smooth muscle tone. Agents Actions 1989; 27: 414-417.
29. McCall T. B., Boughton-Smith N. K., Palmer R. M. J., Whittle B. J. R., Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anions. Biochem J 1989; 261: 293-296.
30. Ialenti A., Ianaro A., Moncada S., Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992; 211: 177-182.
31. Hughes S. R., Williams T. J., Brain S. D. Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol 1990; 191: 481-484.
32. Ialenti A., Moncada S., Di Rosa M. Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 1993; 110: 701-706.
33. McCartney-Francis N., Allen J. B., Mizel D. E. et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993; 178: 749-754.
34. Iuvone T., Carnuccio R., Di Rosa M. Modulation of granuloma formation by endogenous nitric oxide. Eur J Pharmacol 1994; 265: 89-92.
35. Wei X., Charles I. G., Smith A. et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375: 408-411.
36. Xie W, Robertson D. L., Simmons D. L. Mitogen-inducible prostaglandin G\H synthase: a new target for non-steroidal anti-inflammatory drugs. Drug Dev Res 1992; 25: 249-265.
37. Smith W. L. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989; 259: 315-329.
38. Vane J. Towards a better aspirin. Nature 1994; 367: 215-216.
39. Lee S. H., Soyoola E., Chanmugarn P. et al. Selective expression of mitogen inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992; 267: 25934-25939.
40. Maier J. A. M., Hla T., Machag T. Cyclooxygenase is an immediate early gene induced by interleukin-1 in human endothelial cells. J Biol Chem 1990; 265: 10805-10809.
41. Ferreira S. H., Vane J. R. New aspects of the mode of action of non-steroid anti-inflammatory drugs. Annu Rev Pharmacol 1974; 14: 57-73.
42. Meade E. A., Smith W. L., DeWitt D. L Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610-6614.
43. Mitchell J. A., Akarasereenont P., Thiemermann C., Flower R. G., Vane J. R. Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90: 11693-11697.
44. 2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990; 265: 16737-16740.
45. Masferrer J. L., Zweifel B., Seibert K., Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990; 86: 1375-1379.
46. Masferrer J. L., Seibert K., Zweifel B., Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 1992; 89: 3917-3921.
47. Ding A. H., Nathan C. F., Stuehr D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediate from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141: 2407-2412.
48. Drapier J. C, Wietzerbin J., Hibbs J. B. Jr. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 1988; 18: 1587-1592.
49. 2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol Chem 1992; 373: 897-902.
50. Riese J., Hoff T., Nordhoff A., DeWitt D. L., Resch K., Kaever V. Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J Leukot Biol 1994; 55: 476-482.
51. Arias-Negrete S., Keller K., Chadee K. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem Biophys Res Commun 1995; 208: 582-589.
52. Kilbourn R. G., Belloni P. Endothelial cell production of nitrogen oxides in response to interferon-gamma in combination with tumor necrosis factor, interleukin or endotoxin. J Natl Cancer Inst 1990; 82: 772-776.
53. 1. Agents Actions 1995; 45: 59-64.
54. 2 production by vascular smooth muscle cells. Biochem Biophys Res Commun 1993; 194: 420-424.
55. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci USA 1994; 91: 12168-12172.
56. Corbett J. A., Kwon G., Turk J., McDaniel M. L. IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langherans: activation of cyclooxygenase by nitric oxide. Biochemistry 1993; 32: 13767-13770.
57. Salvemini D., Misko T. P., Masferrer J. L., Seibert K., Currie M. G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993; 90: 7240-7244.
58. 2 isomerase activity by PDGF: involvement of nitric oxide. Arch Biochem Biophys 1994; 312: 240-243.
59. Salvemini D., Seibert K., Masferrer J. L., Misko T. P., Currie M. G., Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 1994; 93: 1940-1947.
60. Weksler B. B., Ley C. W., Jaffe E. A. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and ionophore A23187 J Clin Invest 1978; 62: 923-927
61. Doni M. G., Whittle B. J. R., Palmer R. M. J., Moncada S. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur J Pharmacol 1988; 151: 19-25.
62. Keen M., Pickering S. A. W., Hunt J. A. Modulation of the bradykinin-stimulated release of prostacyclin from endothelial cells. BrJ Pharmacol 1990; 101: 524P.
63. Stadler J., Harbrecht B. G., Di Silvio M. et al. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukot Biol 1993; 53: 165-172.
64. Swierkosz T. A., Mitchell J. A., Warner T. D., Botting R. M., Vane J. R. Co-induction of nitric oxide synthase and cyclooxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 1995; 114: 1335-1342.
65. Stadler J., Stefanovic-Racic M., Billiar T. R. et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991; 147: 3915-3920.
66. Knowles R. G., Merret M., Salter M., Moncada S. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem J 1990; 270: 833-836.
67. 1α 5-HETE and LTC4 in rat lung: comparison of GC/MS, RIA and EIA. Prostaglandins 1986; 32: 857-873.
68. Sautebin L, Di Rosa M. Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats. Eur J Pharmacol 1994; 262: 193-196.
69. Sautebin L,. Ialenti A., Ianaro A., Di Rosa M. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. BrJ Pharmacol 1995; 114: 323-328.
70. Sautebin L., Ialenti A., Ianaro A., Di Rosa M. Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin oedema. Eur J Pharmacol, in press.
71. Salvemini D., Settle S. L., Masferrer J. L., Seibert K., Currie M. G., Needleman P. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 1995; 114: 1171-1178.
72. Salvemini D., Manning P. T., Zweifel B. S. et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 1995; 96: 301-308.
73. Tomlinson A., Appleton I., Moore A. R. et al. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br J Pharmacol 1994; 113: 693-698.
74. Griscavage J. M., Rogers N. E., Sherman M. P., Ignarro L. G. Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J Immunol 1993; 151: 6329-6337.
75. Mitchell J. A., Swierkosz T. A., Warner T. D., Gross S., Thiemermann C., Vane J. R. Regulation of prostacyclin synthesis by the release of endogenous nitric oxide in response to bacterial lipopolysaccharide. Br J Pharmacol 1993; 109: 4P.
76. Vane J. R., Mitchell J. A., Appleton I. et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 1994; 91: 2046-2050.
77. Bailey J. M., Verma M. Analytical procedures for a cryptic messenger RNA that mediates translational control of prostaglandin synthase by glucocorticoids. Anal Biochem 1991; 196: 11-18.
78. BB in vascular smooth muscle cells. Eur J Pharmacol 1992; 216: 379-383.
79. Schultz K. D., Schultz K., Schultz G. Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature 1977; 265: 750-751.
80. Katsuki S., Arnold W., Mittal C., Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 1977; 3: 23-25.
81. Murad F., Mittal C. K., Arnold W. P., Katsuki S., Kimura H. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide and hydroxyl radical and inhibition by hemoglobin and myoglobin. Acta Cyclic Nudeotide Res 1978; 9: 145-158.
82. Feelisch M., Noack E. A. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987; 139: 19-30.
83. Levin R. I., Weksler B. B., Tack-Goldman K. Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells. J Clin Invest 1981; 67: 762-769.
84. 2 by organinc nitrates. Eur Heart J 1988; 9: 25-32.
85. Mehta J., Mehta P., Roberts A., Faro R., Ostrowski N., Brigmon L. Comparative effects of nitroglycerin and nitroprusside on prostacyclin generation in adult human vessel wall. J Am Coll Cardiol 1983; 2: 625-630.
86. 2) generation in rat and human arteries. Res Commun Chem Path Pharmacol 1985; 47: 323-328.
87. Levin R. I., Weksler B. B., Jaffe E. A. The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function. Circulation 1982; 66: 1299-1305.
88. Fitzgerald D. J., Roy L., Robertson R. M., Fitzgerald G. A. The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans. Circulation 1985; 70: 297-302.
89. De Caterina R., Dorso C. R., Tack-Goldman K., Weksler B. B. Nitrates and endothelial prostacyclin production: studies in vitro. Circulation 1985; 71: 176-182.
90. Bennet A., Melhuish P. B., Stamford I. F. Nitrates do not affect prostacyclin formation by rat arteries: this is unrelated to increased vascular prostacyclin formation with age. J Pharm Pharmacol 1987; 38: 1039-1041.
91. Stamler J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78: 931-936.
92. Ignarro L. J. Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism. Biochem Soc Trans 1992; 20: 465-469.
93. Traylor T. G., Sharma V. S. Why NO? Biochemistry 1992; 31: 2847-2849.
94. Van der Ouderaa F. J., Buytenhek M., Slikkerveer F. J., Van Dorp D. A. On the haemprotein character of prostaglandin endoperoxide synthetase. Biochem Biophys Acta. 1979; 372: 29-42.
95. Roth G. J., Machuga E. T., Strittmatter P. The heme-binding properties of prostaglandin synthetase from sheep vesicular gland. J Biol Chem 1981; 256: 10018-10022.
96. Kulmacz R. J., Lands W. E. M. Prostaglandin H synthase. J Biol Chem 1984; 259: 6358-6363.
97. Lambier A. M., Markey C. M., Dunford H. B., Marnett L. J. Spectral properties of the higher oxidation states of prostaglandin H synthase. J Biol Chem 1985; 260: 14894-14896.
98. Karthein R., Nastaincyzk W., Ruf H. H. EPR study of ferric native prostaglandin H synthase and its ferrous NO derivative. Eur J Biochem 1987; 166: 173-180.
99. Kulmacz R. J., Tsai A. L., Palmer G. Heme spin states and peroxide-induced radical species in prostaglandin H synthase. J Biol Chem 1987; 262: 10524-10531.
100. 2 release from the hypothalamus. Proc Natl Acad Sci USA 1992; 89: 11543-11546.
101. Kanner J., Harel S., Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 1992; 27: 46-49.
102. Tsai A. How does NO activate hemeproteins? FEBS Lett 1994; 341: 141-145.
103. Moro M. A., Darley-Usmar V. M., Goodwin D. A. et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA 1994; 91: 6702-6706.
104. Egan R. W., Paxton J., Kuehl F. A. Jr. Mechanisms for irreversible self-deactivation of prostaglandin synthase. J Biol Chem 1976; 251: 7329-7335.
105. Marotta P., Sautebin L., Di Rosa M. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol 1992; 107: 640-641.
106. Raddassi K., Petit J. F., Lemaire G. LPS-induced activation of primed murine peritoneal macrophages is modulated by prostaglandins and cyclic nucleotides. Cell Immunol 1993; 149: 50-64.
107. Bulut V., Severn A., Liew F. Y. Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. Biochem Biophys Res Commun 1993; 195: 1134-1138.
108. Renz H., Gong J. H., Schmidt A., Nain M., Gemsa D. Release of tumor necrosis factor-α from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 1988; 141: 2388-2393.
109. Strieter R. M., Remick D. G., Ward P. A. et al. Cellular and molecular regulation of tumor necrosis factor-α production by pentoxifylline. Biochem Biophys Res Commun 1988; 155: 1230-1236.
110. Endres S., Fulle H. J., Sinha B. et al. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-α and interleukin-1β by human mononuclear cells. Immunol 1991; 72: 56-60.
111. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Mol Chem 1988; 263: 5380-5384.
112. 2 activity and tumor necrosis factor expression in HL-60 cells. J Immunol 1990; 144: 2682-2687.
113. Zabel P., Wolter D. T., Schonharting M. M., Schade U. F. Oxpentifylline in endotoxaemia. Lancet 1989; ii: 1474-1477
114. Pettipher E. R., Wimberly D. J. Cyclooxygenase inhibitors enhance tumour necrosis factor production and mortality in murine endotoxic shock. Cytokine 1994; 6: 500-503.
115. Gaillard T., Mulsch A., Busse R., Klein H., Decker K. Regulation of nitric oxide production by stimulated rat Kupffer cells. Pathobiology 1991; 59: 280-283.
116. Koide M., Kawahara Y., Nakayama I, Tsuda T., Yokoyama M. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. J Biol Chem 1993; 268: 24959-24966.
117. Imai T., Hirata Y., Kanno K, Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J Clin Invest 1994; 93: 543-549.
118. Muhl H., Kunz D., Pfeilschifter J. Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br J Pharmacol 1994; 112: 1-8.
119. Imai Y., Kolb H., Burkart V. Nitric oxide production from macrophages is regulated by arachidonic acid metabolites. Biochem Biophys Res Commun 1993; 197: 105-109.
120. Bonta I. L., Ben-Efreim S. Leukotrienes and prostaglandins mutually govern the antitumoral potential of macrophages. In: Garaci E., Paoletti R., Santoro M. G. eds. Prostaglandins in Cancer Research. Heidelberg: Springer Verlag, 1987: 193.
121. G-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol 1990; 101: 10-12.
122. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87: 3629-3632.
123. Thiemermann G, Vane J. Inhibition of nitric oxide by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990; 182: 591-595.
124. Petros A., Vallance P. Nitric oxide synthase inhibitors in human septic shock. In: Moncada S., Nistico G., Higgs E. A., eds. Nitric Oxide:Brain and Immune System. Portland Press 1993: 259.
125. Franchi A. M., Chaud M., Rettori V., Suburo A., McCann S. M., Gimeno M. Role of nitric oxide in eicosanoid synthesis and uterine motility in estrogen-treated rat uteri. Proc Natl Acad Sci USA 1994; 91: 539-543.
126. Weiner C. P., Lizasoain I., Baylis S. A., Knowles R. G., Charles I. G., Moncada S. Induction of calcium-dependent nitric oxide syntheses by sex hormones. Proc Natl Acad Sci USA 1994; 91: 5212-5216.
127. Utsunomiya I., Nagai S., Oh-ishi S. Differential effects of indomethacin and dexamethasone on cytokine production in carrageenin-induced rat pleurisy. Eur J Pharmacol 1994; 252: 213-218.